Clinical nutrition guidelines of the French speaking society of clinical nutrition and metabolism (SFNEP): Summary of recommendations for adults undergoing non-surgical anticancer treatment

Digestive and Liver Disease

Volumn 46, Issue 8, 2014, Pages 667-674

  Senesse, Pierre ^a   Bachmann, Patrick ^b   Bensadoun, René Jean ^c   Besnard, Isabelle ^d   Bourdel Marchasson, Isabelle ^e   Bouteloup, Corinne ^f   Crenn, Pascal ^g   Goldwasser, François ^h   Guérin, Olivier ^d   Latino Martel, Paule ⁱ   Meuric, Jocelyne ^j   May Lévin, Françoise ^k   Michallet, Mauricette ^l   Vasson, Marie Paule ^m   Hébuterne, Xavier ^d  

^a UNIVERSITÉ PAUL VALÉRY   (France)

^b CENTRE LÉON BÉRARD   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f INRA and University of Auvergne   (France)

^g University of Versailles Saint Quentin en Yvelines   (France)

^h Universitary Hospital Center Cochin Assistance Publique Hôpitaux de Paris ^*  (France)

ⁱ CEMAGREF   (France)

^j Anticancer Center Curie   (France)

^k Fr National League Against Cancer   (France)

^l CENTRE HOSPITALIER LYON SUD   (France)

^m Surgical Department   (France)

more..

Author keywords

Clinical practice; Evidence based; Nutritional care; Oncology

Indexed keywords

ANTIOXIDANT; APPETITE STIMULANT; PROTEIN INTAKE;

ARTICLE; ARTIFICIAL FEEDING; BODY MASS; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER THERAPY; CHEMORADIOTHERAPY; COMORBIDITY; FRANCE; GERIATRIC PATIENT; HUMAN; MALNUTRITION; METABOLISM; NUTRITION; NUTRITION EDUCATION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; ADULT; ADVERSE EFFECTS; CACHEXIA; CALORIC INTAKE; COMPLICATION; DIET SUPPLEMENTATION; DIRECTIVE COUNSELING; HEALTH CARE POLICY; NEOPLASMS; PROTEIN INTAKE;

ADULT; ANTIOXIDANTS; CACHEXIA; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DIRECTIVE COUNSELING; ENERGY INTAKE; HUMANS; NEOPLASMS; NUTRITION ASSESSMENT; NUTRITION POLICY; NUTRITIONAL STATUS;

EID: 84904724370     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.01.160     Document Type: Article

References (100)

1. Fearon K., Strasser F., Anker S.D., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011, 12:489-495.
2. Senesse P., Bachmann P., Bensadoun R.J., et al. Nutrition chez le patient adulte atteint de cancer: introduction. Nutrition Clinique et Métabolisme 2012, 26:149-150.
3. Haute Autorité de S. Recommandations pour la pratique clinique (RPC) 2010.
4. Fearon K., Arends J., Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 2013, 10:90-99.
5. Senesse P., Vasson M.-P. Nutrition chez le patient adulte atteint de cancer: quand et comment évaluer l'état nutritionnel d'un malade atteint de cancer? Comment faire le diagnostic de dénutrition et le diagnostic de dénutrition sévère chez un malade atteint de cancer? Quelles sont les situations les plus à risque de dénutrition?. Nutrition Clinique et Métabolisme 2012, 26:165-188.
6. Sanz Ortiz J., Moreno Nogueira J.A., García de Lorenzo, Mateos A. Protein energy malnutrition (PEM) in cancer patients. Clin Transl Oncol 2008, 10:579-582.
7. Bozzetti F. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 2009, 17:279-284.
8. Loprinzi C.L., Laurie J.A., Wieand H.S., et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 1994, 12:601-607.
9. Thibault R., Goujon N., Le Gallic E., et al. Use of 10-point analogue scales to estimate dietary intake: a prospective study in patients nutritionally at-risk. Clinical Nutrition 2009, 28:134-140.
10. Deans D.A.C., Tan B.H., Wigmore S.J., et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009, 100:63-69.
11. Kruizenga H.M., Wierdsma N.J., Van Bokhorst M.A.E., et al. Screening of nutritional status in The Netherlands. Clinical Nutrition 2003, 22:147-152.
12. Pressoir M., Desné S., Berchery D., et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer 2010, 102:966-971.
13. Wakahara T., Shiraki M., Murase K., et al. Nutritional screening with Subjective Global Assessment predicts hospital stay in patients with digestive diseases. Nutrition 2007, 23:634-639.
14. Gupta D., Lammersfeld C.A., Vashi P.G., et al. Can subjective global assessment of nutritional status predict survival in ovarian cancer?. J Ovarian Res 2008, 1.
15. Martin L., Watanabe S., Fainsinger R., et al. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 2010, 28:4376-4383.
16. Aaldriks A.A., Maartense E., Le Cessie S., et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 2011, 79:205-212.
17. Gioulbasanis I., Baracos V.E., Giannousi Z., et al. Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history. Ann Oncol 2011, 22:835-841.
18. Ravasco P., Monteiro-Grillo I., Marques Vidal P., et al. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005, 27:659-668.
19. Ravasco P., Monteiro-Grillo I., Vidal P.M., et al. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 2005, 23:1431-1438.
20. Isenring E.A., Capra S., Bauer J.D. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 2004, 91:447-452.
21. Isenring E.A., Bauer J.D., Capra S. Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. J Am Diet Assoc 2007, 107:404-412.
22. Garabige V., Giraud P., De Rycke Y., et al. Intérêt de la prise en charge nutritionnelle des patients traités par irradiation des voies aérodigestives supérieures: la consultation diététique est-elle utile?. Cancer Radiother 2007, 11:111-116.
23. van den Berg M.G.A., Rasmussen-Conrad E.L., Wei K.H., et al. Comparison of the effect of individual dietary counselling and of standard nutritional care on weight loss in patients with head and neck cancer undergoing radiotherapy. British J Nutr 2010, 104:872-877.
24. Odelli C., Burgess D., Bateman L., et al. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol 2005, 17:639-645.
25. McCarthy D., Weihofen D. The effect of nutritional supplements on food intake in patients undergoing radiotherapy. Oncol Nurs Forum 1999, 26:897-900.
26. Nayel H., el-Ghoneimy E., el-Haddad S. Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumors treated with irradiation. Nutrition 1992, 8:13-18.
27. Lee H., Havrila C., Bravo V., et al. Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 2008, 16:285-289.
28. Piquet M.A., Ozsahin M., Larpin I., et al. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer 2002, 10:502-504.
29. Beer K.T., Krause K.B., Zuercher T., et al. Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer. Nutr Cancer 2005, 52:29-34.
30. Mangar S., Slevin N., Mais K., et al. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review. Radiother Oncol 2006, 78:152-158.
31. Nugent B., Lewis S., O'Sullivan J.M. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev 2010.
32. Corry J., Poon W., McPhee N., et al. Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo) radiation. J Med Imaging Radiat Oncol 2008, 52:503-510.
33. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004, 350:1945-1952.
34. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004, 350:1937-1944.
35. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003, 66:253-262.
36. Ang K.K., Zhang Q., Wheeler R.H., et al. A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome. J Clin Oncol 2010, 28.
37. Corry J., Poon W., McPhee N., et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo) radiation. Head Neck 2009, 31:867-876.
38. Salas S., Baumstarck-Barrau K., Alfonsi M., et al. Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: prospective randomized trial. Radiother Oncol 2009, 93:503-509.
39. Silander E., Nyman J., Bove M., et al. Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer - a randomized study. Head Neck 2012, 34:1-9.
40. Assenat E., Thezenas S., Flori N., et al. Prophylactic percutaneous endoscopic gastrostomy in patients with advanced head and neck tumors treated by combined chemoradiotherapy. J Pain Symptom Manage 2011, 42:548-556.
41. Atasoy B.M., Yonal O., Demirel B., et al. The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy. Eur Arch Otorhinolaryngol 2012, 269:275-282.
42. Raykher A., Correa L., Russo L., et al. The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. JPEN J Parenter Enteral Nutr 2009, 33:404-410.
43. Lawenda B.D., Kelly K.M., Ladas E.J., et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?. J Natl Cancer Inst 2008, 100:773-783.
44. Bairati I., Meyer F., Gélinas M., et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005, 97:481-488.
45. Meyer F., Bairati I., Fortin A., et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 2008, 122:1679-1683.
46. Assenat E., Latournerie M., Thézenas S., et al. A prospective phase II study evaluating the efficacy of oral immune modulating formulae on acute oral mucositis during radiochemotherapy in head and neck neoplasms. ESPEN J 2011, 6:e171-e177.
47. Hovan A.J., Williams P.M., Stevenson-Moore P., et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 2010, 18:1081-1087.
48. Evans W.K., Nixon D.W., Daly J.M., et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 1987, 5:113-124.
49. Ovesen L., Allingstrup L., Hannibal J., et al. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993, 11:2043-2049.
50. Baldwin C., McGough C., Norman A.R., et al. Failure of dietetic referral in patients with gastrointestinal cancer and weight loss. Eur J Cancer 2006, 42:2504-2509.
51. Bozzetti F., Arends J., Lundholm K., et al. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clinical Nutrition 2009, 28.
52. Zaloga G.P. Parenteral nutrition in adult inpatients with functioning gastrointestinal tracts: assessment of outcomes. Lancet 2006, 367:1101-1111.
53. Koretz R.L., Lipman T.O., Klein S. AGA technical review on parenteral nutrition. Gastroenterology 2001, 121:970-1001.
54. Block K.I., Koch A.C., Mead M.N., et al. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer 2008, 123:1227-1239.
55. Alexandre J., Batteux F., Nicco C., et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 2006, 119:41-48.
56. Hwang P.M., Bunz F., Yu J., et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 2001, 7:1111-1117.
57. Hébuterne X., Bensadoun R.-J. Nutrition chez le patient adulte atteint de cancer: place de la pharmaconutrition en cancérologie. Nutrition Clinique et Métabolisme 2012, 26:247-268.
58. Stokman M.A., Spijkervet F.K.L., Boezen H.M., et al. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 2006, 85:690-700.
59. Worthington H.V., Clarkson J.E., Eden O.B. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2007.
60. Dupertuis Y.M., Meguid M.M., Pichard C. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 2007, 10:427-432.
61. Bougnoux P., Hajjaji N., Ferrasson M.N., et al. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 2009, 101:1978-1985.
62. Murphy R.A., Mourtzakis M., Chu Q.S.C., et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 2011, 117:3774-3780.
63. Hutton J.L., Baracos V.E., Wismer W.V. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 2007, 33:156-165.
64. Hopkinson J.B., Okamoto I., Addington-Hall J.M. What to eat when off treatment and living with involuntary weight loss and cancer: a systematic search and narrative review. Support Care Cancer 2011, 19:1-17.
65. Wallengren O., Bosaeus I., Lundholm K. Dietary energy density is associated with energy intake in palliative care cancer patients. Support Care Cancer 2012, 20:2851-2857.
66. Lundholm K., Daneryd P., Bosaeus I., et al. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 2004, 100:1967-1977.
67. Bozzetti F., Cozzaglio L., Biganzoli E., et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 2002, 21:281-288.
68. McCann Rm H.W.J. Comfort care for terminally ill patients: the appropriate use of nutrition and hydration. JAMA 1994, 272:1263-1266.
69. Bruera E., Sala R., Rico M.A., et al. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol 2005, 23:2366-2371.
70. Crenn P. Nutrition chez le patient adulte atteint de cancer: orexigènes et autres médicaments anticachectisants. Nutrition Clinique et Métabolisme 2012, 26:269-277.
71. Pascual López A., Roqué i Figuls M., Urrútia Cuchi G., et al. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage 2004, 27:360-369.
72. Berenstein E.G., Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005.
73. Jatoi A., Windschitl H.E., Loprinzi C.L., et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002, 20:567-573.
74. Gogos C.A., Ginopoulos P., Salsa B., et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998, 82:395-402.
75. Jatoi A., Rowland K., Loprinzi C.L., et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004, 22:2469-2476.
76. Fearon K.C.H., Von Meyenfeldt M.F., Moses A.G.W., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003, 52:1479-1486.
77. Fearon K.C.H., Barber M.D., Moses A.G., et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 2006, 24:3401-3407.
78. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
79. Murray S.M., Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 2009.
80. Seguy D., Berthon C., Micol J.-B., et al. Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning. Transplantation 2006, 82:835-839.
81. Sefcick A., Anderton D., Byrne J.L., et al. Naso-jejunal feeding in allogeneic bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant 2001, 28:1135-1139.
82. Roberts S., Miller J., Pineiro L., et al. Total parenteral nutrition vs. oral diet in autologous hematopoietic cell transplant recipients. Bone Marrow Transplant 2003, 32:715-721.
83. Skop A., Kolarzyk E., Skotnicki A.B. Importance of parenteral nutrition in patients undergoing hemopoietic stem cell transplantation procedures in the autologous system. JPEN J Parenter Enteral Nutr 2005, 29:241-247.
84. Mulder P.O., Bouman J.G., Gietema J.A., et al. Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutrition. Cancer 1989, 64:2045-2052.
85. Sheean P.M., Freels S.A., Helton W.S., et al. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:656-664.
86. Ziegler T.R., Young L.S., Benfell K., et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992, 116:821-828.
87. Crowther M., Avenell A., Culligan D.J. Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplant 2009, 44:413-425.
88. Pytlík R., Gregora E., Benes P., et al. Effect of parenteral glutamine on restoration of lymphocyte subpopulations after high-dose chemotherapy and autologous hematopoietic cell transplantation: data from a double-blind randomized study. Epidemiol Mikrobiol Imunol 2002, 51:152-155.
89. Scheid C., Hermann K., Kremer G., et al. Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy. Nutrition 2004, 20:249-254.
90. Sornsuvit C., Komindr S., Chuncharunee S., et al. Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients. J Int Med Res 2008, 36:1383-1391.
91. Sykorova A., Horacek J., Zak P., et al. A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies - three years' follow-up. Neoplasma 2005, 52:476-482.
92. Szeluga D.J., Stuart R.K., Brookmeyer R., et al. Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987, 47:3309-3316.
93. Cheney C.L., Weiss N.S., Fisher L.D., et al. Oral protein intake and the risk of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant 1991, 8:203-210.
94. Toliusiene J., Lesauskaite V. The nutritional status of older men with advanced prostate cancer and factors affecting it. Support Care Cancer 2004, 12:716-719.
95. Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55:241-252.
96. Pallis A.G., Fortpied C., Wedding U., et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010, 46:1502-1513.
97. Blanc-Bisson C., Fonck M., Rainfray M., et al. Undernutrition in elderly patients with cancer: target for diagnosis and intervention. Crit Rev Oncol Hematol 2008, 67:243-254.
98. Stanga Z., Brunner A., Leuenberger M., et al. Nutrition in clinical practice-the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr 2008, 62:687-694.
99. Boateng A.A., Sriram K., Meguid M.M., et al. Refeeding syndrome: treatment considerations based on collective analysis of literature case reports. Nutrition 2010, 26:156-167.
100. Cruz I., Mamel J.J., Brady P.G., et al. Incidence of abdominal wall metastasis complicating PEG tube placement in untreated head and neck cancer. Gastrointest Endosc 2005, 62:708-711.